NAT-LETROZOLE DIN 02421585
Health Canada record
| Active ingredient(s) | LETROZOLE 2.5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L02BG04 LETROZOLE |
| Original market date | 03-Feb-2015 |
| Current status date | 03-Feb-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Natco Pharma (Canada) Inc — licence 102058, currently licensed, last inspection rating C (2022-07-26).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing LETROZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02338459 | ACH-LETROZOLE | ACCORD HEALTHCARE INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02543419 | AG-LETROZOLE TABLETS | ANGITA PHARMA INC. | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02358514 | APO-LETROZOLE | APOTEX INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02392496 | BIO-LETROZOLE | BIOMED PHARMA | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02231384 | FEMARA | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02370794 | IPG-LETROZOLE | MARCAN PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Approved |
| 02541912 | JAMP LETROZOLE TABLETS | JAMP PHARMA CORPORATION | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02504472 | LETROZOLE | SANIS HEALTH INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02524244 | LETROZOLE | SIVEM PHARMACEUTICALS ULC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02402025 | LETROZOLE | PRO DOC LIMITEE | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02549972 | M-LETROZOLE | MANTRA PHARMA INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02373424 | MAR-LETROZOLE | MARCAN PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02508109 | MINT-LETROZOLE | MINT PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02520486 | NRA-LETROZOLE | NORA PHARMA INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02309114 | PMS-LETROZOLE | PHARMASCIENCE INC | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02398656 | RIVA-LETROZOLE | LABORATOIRE RIVA INC. | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02344815 | SANDOZ LETROZOLE | SANDOZ CANADA INCORPORATED | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02343657 | TEVA-LETROZOLE | TEVA CANADA LIMITED | Tablet | LETROZOLE 2.5 MG | Marketed |
| 02406330 | ACCEL-LETROZOLE TABLETS USP | ACCEL PHARMA INC | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02374439 | AG-LETROZOLE | ANGITA PHARMA INC. | Tablet | LETROZOLE 2.5 MG | Dormant |
| 02404400 | AURO-LETROZOLE | AURO PHARMA INC | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02459884 | CCP-LETROZOLE | CELLCHEM PHARMACEUTICALS INC. | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02352052 | CO LETROZOLE | COBALT PHARMACEUTICALS COMPANY | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02316374 | DOM-LETROZOLE | DOMINION PHARMACAL | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02373009 | JAMP-LETROZOLE | JAMP PHARMA CORPORATION | Tablet | LETROZOLE 2.5 MG | Dormant |
| 02348969 | LETROZOLE | ACTAVIS PHARMA COMPANY | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02348896 | LETROZOLE | MELIAPHARM INC | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02347997 | LETROZOLE | TEVA CANADA LIMITED | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02375273 | LETROZOLE SUN | TARO PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02381958 | LETROZOLE TABLETS | FRESENIUS KABI CANADA LTD | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02322315 | MED-LETROZOLE | GENERIC MEDICAL PARTNERS INC | Tablet | LETROZOLE 2.5 MG | Dormant |
| 02372169 | MYL-LETROZOLE | MYLAN PHARMACEUTICALS ULC | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02322544 | MYLAN-LETROZOLE | MYLAN PHARMACEUTICALS ULC | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02316366 | PHL-LETROZOLE | PHARMEL INC | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02504286 | PRIVA-LETROZOLE | PHARMAPAR INC | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02431335 | STASON-LETROZOLE | VPI PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Cancelled Pre Market |
| 02372282 | TARO-LETROZOLE | SUN PHARMA CANADA INC | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02428156 | VAN-LETROZOLE | VANC PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Cancelled Post Market |
| 02378213 | ZINDA-LETROZOLE | STASON PHARMACEUTICALS INC | Tablet | LETROZOLE 2.5 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 16979 | 2015-06-09 | Abbreviated New Drug Submission (ANDS) | |
| 15427 | 2014-03-19 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
International API supply for LETROZOLE
9 valid EDQM Certificates of Suitability from 9 holders. 13 active FDA Drug Master Files.
Request a quote for NAT-LETROZOLE